← Leaderboards
Simon Andrew Gayther
University Of Southern California
$9,015,265
Attributed
$21,154,211
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2010–24$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$21,154,211 · 8
By mechanism
R01$20,992,550 · 7
R03$161,661 · 1
Top collaborators
- Paul Pharoah11 shared
- Matthew L Freedman9 shared
- J. Keith Joung6 shared
- Alexander Gusev5 shared
- Susan J Ramus5 shared
- Joellen M. Schildkraut5 shared
- Thomas A Sellers4 shared
- Siddhartha Kar3 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Paul Pharoah$1,833,190
- Susan J Ramus$3,904,113
- Celeste Leigh Pearce$4,768,851
- Melanie R Palomares$3,261,023
- Amir H Kashani$11,509,148
Others in their field
Top investigators on “Malignant Neoplasm Of Ovary”
- David Heimbrook · Leidos Biomedical Research, Inc.$212,807,834
- Philip J Disaia · University Of California Irvine$127,836,851
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$32,228,202
- Larry Arthur$28,462,007
- Weiping Zou · University Of Michigan At Ann Arbor$24,295,958
- Robert C Bast · University Of Texas Md Anderson Can Ctr$22,987,143
Research focus
Malignant Neoplasm Of OvaryMalignant NeoplasmsGenesVariantCancer RiskGenotypeBrca1 GeneGenetic VariantSusceptibility GeneGenome-WideRisk VariantCase ControlBrca2 GeneGenome Wide Association StudyGeneticBasePenetranceOvarianGenomeHeritabilityTissuesAllelesTraitCandidate Disease Gene
Grant awards (35)
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$614,121
R01 · FY2024 · CA · contact PI
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci$599,202
R01 · FY2024 · CA · contact PI
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$643,149
R01 · FY2023 · CA · contact PI
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci$622,687
R01 · FY2023 · CA · contact PI
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci$668,422
R01 · FY2022 · CA · contact PI
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$663,739
R01 · FY2022 · CA · contact PI
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers$548,271
R01 · FY2022 · CA
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$688,012
R01 · FY2021 · CA · contact PI
Functional Effects of Ovarian Cancer Risk Variants$612,989
R01 · FY2021 · CA · contact PI
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers$569,270
R01 · FY2021 · CA
Epidemiology and biology of lncRNAs in ovarian cancer$786,838
R01 · FY2020 · CA
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$698,082
R01 · FY2020 · CA · contact PI
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers$680,370
R01 · FY2020 · CA
Functional Effects of Ovarian Cancer Risk Variants$618,508
R01 · FY2020 · CA · contact PI
Epidemiology and biology of lncRNAs in ovarian cancer$680,786
R01 · FY2019 · CA
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers$638,982
R01 · FY2019 · CA
Functional Effects of Ovarian Cancer Risk Variants$598,208
R01 · FY2019 · CA · contact PI
Epidemiology and biology of lncRNAs in ovarian cancer$871,042
R01 · FY2018 · CA
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers$703,749
R01 · FY2018 · CA
Functional Effects of Ovarian Cancer Risk Variants$622,079
R01 · FY2018 · CA · contact PI
Functional Effects of Ovarian Cancer Risk Variants$149,945
R01 · FY2018 · CA · contact PI
Epidemiology and biology of lncRNAs in ovarian cancer$97,393
R01 · FY2018 · CA
Epidemiology and biology of lncRNAs in ovarian cancer$951,947
R01 · FY2017 · CA
Functional Effects of Ovarian Cancer Risk Variants$686,463
R01 · FY2017 · CA · contact PI
The contribution of rare alleles to ovarian cancer in the population$549,009
R01 · FY2017 · CA · contact PI
Epidemiology and biology of lncRNAs in ovarian cancer$991,197
R01 · FY2016 · CA
The contribution of rare alleles to ovarian cancer in the population$617,338
R01 · FY2016 · CA · contact PI
The contribution of rare alleles to ovarian cancer in the population$609,595
R01 · FY2015 · CA · contact PI
The contribution of rare alleles to ovarian cancer in the population$598,855
R01 · FY2014 · CA · contact PI
LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel$79,661
R03 · FY2014 · CA · contact PI
The contribution of rare alleles to ovarian cancer in the population$658,630
R01 · FY2013 · CA · contact PI
LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel$82,000
R03 · FY2013 · CA · contact PI
Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data$605,846
R01 · FY2012 · CA
Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data$631,470
R01 · FY2011 · CA
Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data$716,356
R01 · FY2010 · CA